| Dr Helen Shnol, DPM | |
|
5400 Balboa Blvd Ste 325, Encino, CA 91316-5226 | |
| (818) 907-6100 | |
| Not Available |
| Full Name | Dr Helen Shnol |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 7 Years |
| Location | 5400 Balboa Blvd Ste 325, Encino, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295258366 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centinela Hospital Medical Center | Inglewood, CA | Hospital |
| Saint Francis Medical Center | Lynwood, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wound Institute Of America | 8123310471 | 7 |
News Archive
The more dots there are, the more accurate a picture you get when you connect them. Cancer researchers adopting that philosophy have developed a new imaging technology that could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what is going on in individual tumor cells.
NEARLY a thousand deaths from breast cancer could be avoided each year if short term survival rates in England were among the best comparable countries in Europe, according to research presented at the National Cancer Intelligence Network conference today.
In a mouse model, University of Pennsylvania School of Medicine researchers discovered that olfactory sensory neurons expressing the same receptor responded to a specific odor with an array of speeds and sensitivities, a phenomenon previously not detected in the mammalian sense of smell.
A world-first transitional pain program that aims to stop pain from becoming chronic after surgery is being pioneered at Toronto General Hospital, University Health Network.
Pro-Pharmaceuticals, Inc., today announced that it has closed a $325,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date from the 10X Fund to approximately $4.4 million.
› Verified 7 days ago
| Provider Name | Vladimir Zeetser, Dpm, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1518972967 PECOS PAC ID: 9931163342 Enrollment ID: O20041116000467 |
News Archive
The more dots there are, the more accurate a picture you get when you connect them. Cancer researchers adopting that philosophy have developed a new imaging technology that could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what is going on in individual tumor cells.
NEARLY a thousand deaths from breast cancer could be avoided each year if short term survival rates in England were among the best comparable countries in Europe, according to research presented at the National Cancer Intelligence Network conference today.
In a mouse model, University of Pennsylvania School of Medicine researchers discovered that olfactory sensory neurons expressing the same receptor responded to a specific odor with an array of speeds and sensitivities, a phenomenon previously not detected in the mammalian sense of smell.
A world-first transitional pain program that aims to stop pain from becoming chronic after surgery is being pioneered at Toronto General Hospital, University Health Network.
Pro-Pharmaceuticals, Inc., today announced that it has closed a $325,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date from the 10X Fund to approximately $4.4 million.
› Verified 7 days ago
| Provider Name | Home Foot Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447480785 PECOS PAC ID: 4981744257 Enrollment ID: O20091217000066 |
News Archive
The more dots there are, the more accurate a picture you get when you connect them. Cancer researchers adopting that philosophy have developed a new imaging technology that could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what is going on in individual tumor cells.
NEARLY a thousand deaths from breast cancer could be avoided each year if short term survival rates in England were among the best comparable countries in Europe, according to research presented at the National Cancer Intelligence Network conference today.
In a mouse model, University of Pennsylvania School of Medicine researchers discovered that olfactory sensory neurons expressing the same receptor responded to a specific odor with an array of speeds and sensitivities, a phenomenon previously not detected in the mammalian sense of smell.
A world-first transitional pain program that aims to stop pain from becoming chronic after surgery is being pioneered at Toronto General Hospital, University Health Network.
Pro-Pharmaceuticals, Inc., today announced that it has closed a $325,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date from the 10X Fund to approximately $4.4 million.
› Verified 7 days ago
| Provider Name | Wound Institute Of America |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437505393 PECOS PAC ID: 8123310471 Enrollment ID: O20160707001617 |
News Archive
The more dots there are, the more accurate a picture you get when you connect them. Cancer researchers adopting that philosophy have developed a new imaging technology that could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what is going on in individual tumor cells.
NEARLY a thousand deaths from breast cancer could be avoided each year if short term survival rates in England were among the best comparable countries in Europe, according to research presented at the National Cancer Intelligence Network conference today.
In a mouse model, University of Pennsylvania School of Medicine researchers discovered that olfactory sensory neurons expressing the same receptor responded to a specific odor with an array of speeds and sensitivities, a phenomenon previously not detected in the mammalian sense of smell.
A world-first transitional pain program that aims to stop pain from becoming chronic after surgery is being pioneered at Toronto General Hospital, University Health Network.
Pro-Pharmaceuticals, Inc., today announced that it has closed a $325,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date from the 10X Fund to approximately $4.4 million.
› Verified 7 days ago
| Provider Name | Jeffrey Demian Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306339759 PECOS PAC ID: 4880944339 Enrollment ID: O20180905001021 |
News Archive
The more dots there are, the more accurate a picture you get when you connect them. Cancer researchers adopting that philosophy have developed a new imaging technology that could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what is going on in individual tumor cells.
NEARLY a thousand deaths from breast cancer could be avoided each year if short term survival rates in England were among the best comparable countries in Europe, according to research presented at the National Cancer Intelligence Network conference today.
In a mouse model, University of Pennsylvania School of Medicine researchers discovered that olfactory sensory neurons expressing the same receptor responded to a specific odor with an array of speeds and sensitivities, a phenomenon previously not detected in the mammalian sense of smell.
A world-first transitional pain program that aims to stop pain from becoming chronic after surgery is being pioneered at Toronto General Hospital, University Health Network.
Pro-Pharmaceuticals, Inc., today announced that it has closed a $325,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date from the 10X Fund to approximately $4.4 million.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Helen Shnol, DPM 271 N Holliston Ave Apt C, Pasadena, CA 91106-1546 Ph: () - | Dr Helen Shnol, DPM 5400 Balboa Blvd Ste 325, Encino, CA 91316-5226 Ph: (818) 907-6100 |
News Archive
The more dots there are, the more accurate a picture you get when you connect them. Cancer researchers adopting that philosophy have developed a new imaging technology that could give scientists the ability to simultaneously measure as many as 100 or more distinct features in or on a single cell. In a disease such as cancer, that capability would provide a much better picture of what is going on in individual tumor cells.
NEARLY a thousand deaths from breast cancer could be avoided each year if short term survival rates in England were among the best comparable countries in Europe, according to research presented at the National Cancer Intelligence Network conference today.
In a mouse model, University of Pennsylvania School of Medicine researchers discovered that olfactory sensory neurons expressing the same receptor responded to a specific odor with an array of speeds and sensitivities, a phenomenon previously not detected in the mammalian sense of smell.
A world-first transitional pain program that aims to stop pain from becoming chronic after surgery is being pioneered at Toronto General Hospital, University Health Network.
Pro-Pharmaceuticals, Inc., today announced that it has closed a $325,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date from the 10X Fund to approximately $4.4 million.
› Verified 7 days ago
Dawn R. Buratti, D.p.m., Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 5400 Balboa Blvd Ste 325, Encino, CA 91316 Phone: 818-701-6300 Fax: 866-513-4995 | |
Gilman Podiatry, A Prof. Corp Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 17777 Ventura Blvd, Suite 230, Encino, CA 91316 Phone: 818-905-1000 Fax: 818-342-1609 | |
Tower Podiatry-the Foot And Ankle Surgical Institute Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 16661 Ventura Blvd, Suite 705, Encino, CA 91436 Phone: 310-657-2828 Fax: 310-657-9733 | |
Leonora Fihman, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5400 Balboa Blvd, Encino, CA 91316 Phone: 818-907-6100 | |
Maurice R Masliah Dpm Podiatrist Medicare: Medicare Enrolled Practice Location: 5400 Balboa Blvd Ste 225, Encino, CA 91316 Phone: 818-981-3344 Fax: 818-981-4777 | |
Dr. Majid Seyedin, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 17777 Ventura Blvd, 252, Encino, CA 91316 Phone: 323-912-9220 Fax: 818-221-0534 | |
Leonora Fihman, Dpm, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 5400 Balboa Blvd, 321, Encino, CA 91316 Phone: 818-907-6110 |